RPID logo

Rapid Micro Biosystems Stock Price

Symbol: NasdaqCM:RPIDMarket Cap: US$145.9mCategory: Pharmaceuticals & Biotech

RPID Share Price Performance

Recent RPID News & Updates

No updates

Rapid Micro Biosystems, Inc. Key Details

US$29.6m

Revenue

US$27.8m

Cost of Revenue

US$1.8m

Gross Profit

US$46.6m

Other Expenses

-US$44.8m

Earnings

Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
Aug 12, 2025
Earnings per share (EPS)
-1.02
Gross Margin
6.13%
Net Profit Margin
-151.22%
Debt/Equity Ratio
0%

Rapid Micro Biosystems, Inc. Competitors

 
 
 
 
 
 
 
 
 
 
 
 

About RPID

Founded
2006
Employees
163
CEO
Robert Spignesi
WebsiteView website
www.rapidmicrobio.com

Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes growth direct system, proprietary consumables, lab information management system connection software, and customer support and validation services. Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company also provides onsite technical training services. Its solutions are used in environmental monitoring, water, bioburden, and sterility release testing applications. In addition, the company offers RMBNucleus Mold Alarm software; and Growth Direct LIMS connection software. Rapid Micro Biosystems, Inc. was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. The company was incorporated in 2006 and is headquartered in Lexington, Massachusetts.

U.S. Market Performance

  • 7 Days: -2.7%
  • 3 Months: 10.1%
  • 1 Year: 17.7%
  • Year to Date: 5.9%
The market has dropped by 18% in the last 7 days, with the Financials sector leading declines. As for the longer term, the market has actually risen by 18% in the last year. Looking forward, earnings are forecast to grow by 15% annually. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading